Bank of China Limited (601988.SS) vs AbbVie Inc. (ABBV)

See how Bank of China Limited and AbbVie Inc. differ across market data and performance, so you can decide which asset best fits your strategy.

$1.11
Shanghai
Bank of China Limited is one of China’s largest commercial banks and has one of the country’s strongest international banking networks. It provides corporate banking, personal banking, trade finance, foreign exchange, wealth management, and treasury services. The bank has a long history in cross-border finance and serves Chinese companies, global corporates, governments, and retail clients. Its performance is influenced by Chinese economic growth, international trade, interest-rate spreads, credit quality, currency activity, and government policy.
View Full Page
$294.55
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page

Key Metrics Comparison

Bank of China Limited601988.SS
Market Cap
$356.284B
Price
$1.11
24h Change
+0.68%
24h Volume
$227.7M
Employees
313,746
Shares Outstanding
N/A
AbbVie Inc.ABBV
Market Cap
$520.651B
Price
$294.55
24h Change
-0.16%
24h Volume
$4.71M
Employees
57,000
Shares Outstanding
1,768,169,012

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
601988.SS
40.6%
ABBV
59.4%

Volume Share

Share of combined 24h volume

Volume Share
601988.SS
98.0%
ABBV
2.0%

24h Performance

Price change over last 24 hours

24h Performance
601988.SS
0.68%
ABBV
-0.16%
Price Comparison
Bank of China Limited
AbbVie Inc.